Developers of the most energy-efficient, lowest-cost CO2 separation & capture system.
ST. LOUIS, MISSOURI
Problem they are Solving?
The need for less expensive and less electricity-intensive carbon capture and sequestration (CCS) technologies.
Their Solution?
A patented enzyme immobilization and stabilization polymer technology that potentially cuts the cost of CCS by more than half and puts the resulting captured carbon to work in a variety of potential uses.
Chrysalix take from Portfolio Manager, Mike Walkinshaw
1.
What is the insight that led to Chrysalix investing?
The
intersection of biology with energy markets is showing great promise. The
ability to encapsulate an enzyme and allow it to retain its function outside of
its host is a unique and valuable capability. We see the Akermin technology
enabling economic large scale separation and capture of CO2 for sequestration.
2. What is the company’s
biggest strength?
The
scientific team is highly entrepreneurial and innovative and continues to
enable the cross-over of biological science into new functional areas. Their
IP position is strong and they have developed key industry relationships over
the past few years.
3. What is the implication
of this company being successful?
Global
warming is the defining issue of our times. The ability to capture CO2 from a
coal power plant flue gas stream at a very low cost will be fundamental to the
continuance of our current lifestyles.
